DE602005009702D1 - Esr1 und gebärmutterhalskrebs - Google Patents

Esr1 und gebärmutterhalskrebs

Info

Publication number
DE602005009702D1
DE602005009702D1 DE602005009702T DE602005009702T DE602005009702D1 DE 602005009702 D1 DE602005009702 D1 DE 602005009702D1 DE 602005009702 T DE602005009702 T DE 602005009702T DE 602005009702 T DE602005009702 T DE 602005009702T DE 602005009702 D1 DE602005009702 D1 DE 602005009702D1
Authority
DE
Germany
Prior art keywords
esr1
cancer
nutritional
nutritional cancer
kits
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE602005009702T
Other languages
English (en)
Inventor
Der Zee Ate Van
Bea Wisman
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
OncoMethylome Sciences SA
Original Assignee
OncoMethylome Sciences SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB0415988A external-priority patent/GB0415988D0/en
Application filed by OncoMethylome Sciences SA filed Critical OncoMethylome Sciences SA
Publication of DE602005009702D1 publication Critical patent/DE602005009702D1/de
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/154—Methylation markers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/16—Primer sets for multiplex assays
DE602005009702T 2004-07-16 2005-07-07 Esr1 und gebärmutterhalskrebs Expired - Fee Related DE602005009702D1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US58835004P 2004-07-16 2004-07-16
GB0415988A GB0415988D0 (en) 2004-07-16 2004-07-16 ESR1 and cervical cancer
PCT/EP2005/007338 WO2006007980A2 (en) 2004-07-16 2005-07-07 Esr1 and cervical cancer

Publications (1)

Publication Number Publication Date
DE602005009702D1 true DE602005009702D1 (de) 2008-10-23

Family

ID=35064764

Family Applications (1)

Application Number Title Priority Date Filing Date
DE602005009702T Expired - Fee Related DE602005009702D1 (de) 2004-07-16 2005-07-07 Esr1 und gebärmutterhalskrebs

Country Status (6)

Country Link
US (1) US20090023137A1 (de)
EP (2) EP1985715A3 (de)
AT (1) ATE408032T1 (de)
CA (1) CA2574165A1 (de)
DE (1) DE602005009702D1 (de)
WO (1) WO2006007980A2 (de)

Families Citing this family (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060078893A1 (en) 2004-10-12 2006-04-13 Medical Research Council Compartmentalised combinatorial chemistry by microfluidic control
GB0307403D0 (en) * 2003-03-31 2003-05-07 Medical Res Council Selection by compartmentalised screening
GB0307428D0 (en) * 2003-03-31 2003-05-07 Medical Res Council Compartmentalised combinatorial chemistry
US20050221339A1 (en) * 2004-03-31 2005-10-06 Medical Research Council Harvard University Compartmentalised screening by microfluidic control
US7968287B2 (en) 2004-10-08 2011-06-28 Medical Research Council Harvard University In vitro evolution in microfluidic systems
WO2006088940A2 (en) * 2005-02-14 2006-08-24 The Johns Hopkins University Neoplasia screening compositions and methods of use
CA2636855C (en) 2006-01-11 2016-09-27 Raindance Technologies, Inc. Microfluidic devices and methods of use in the formation and control of nanoreactors
US7901882B2 (en) * 2006-03-31 2011-03-08 Affymetrix, Inc. Analysis of methylation using nucleic acid arrays
EP2047910B1 (de) 2006-05-11 2012-01-11 Raindance Technologies, Inc. Mikrofluidische Vorrichtung und Verfahren
US9562837B2 (en) 2006-05-11 2017-02-07 Raindance Technologies, Inc. Systems for handling microfludic droplets
EP2077912B1 (de) 2006-08-07 2019-03-27 The President and Fellows of Harvard College Fluorkohlenstoffemulsionsstabilisierende tenside
US8772046B2 (en) 2007-02-06 2014-07-08 Brandeis University Manipulation of fluids and reactions in microfluidic systems
WO2008130623A1 (en) 2007-04-19 2008-10-30 Brandeis University Manipulation of fluids, fluid components and reactions in microfluidic systems
EP2626435B1 (de) * 2008-03-21 2016-06-01 MDxHealth S.A. Erkennung und Prognose von Gebärmutterhalskrebs
WO2010009365A1 (en) * 2008-07-18 2010-01-21 Raindance Technologies, Inc. Droplet libraries
WO2010111231A1 (en) 2009-03-23 2010-09-30 Raindance Technologies, Inc. Manipulation of microfluidic droplets
WO2010125117A2 (en) * 2009-04-29 2010-11-04 Ralph Wirtz A method to assess prognosis and to predict therapeutic success in cancer by determining hormone receptor expression levels
WO2011042564A1 (en) 2009-10-09 2011-04-14 Universite De Strasbourg Labelled silica-based nanomaterial with enhanced properties and uses thereof
EP2517025B1 (de) 2009-12-23 2019-11-27 Bio-Rad Laboratories, Inc. Verfahren zur reduzierung des austauschs von molekülen zwischen tröpfchen
US9366632B2 (en) 2010-02-12 2016-06-14 Raindance Technologies, Inc. Digital analyte analysis
US9399797B2 (en) 2010-02-12 2016-07-26 Raindance Technologies, Inc. Digital analyte analysis
EP2534267B1 (de) 2010-02-12 2018-04-11 Raindance Technologies, Inc. Digitale analyse von analyten
US10351905B2 (en) 2010-02-12 2019-07-16 Bio-Rad Laboratories, Inc. Digital analyte analysis
KR101374822B1 (ko) * 2010-04-23 2014-03-17 (주)지노믹트리 자궁경부암 진단용 메틸화 마커
WO2012045012A2 (en) 2010-09-30 2012-04-05 Raindance Technologies, Inc. Sandwich assays in droplets
EP2673614B1 (de) 2011-02-11 2018-08-01 Raindance Technologies, Inc. Verfahren zur bildung gemischter tröpfchen
EP2675819B1 (de) 2011-02-18 2020-04-08 Bio-Rad Laboratories, Inc. Zusammensetzungen und verfahren für molekulare etikettierung
DE202012013668U1 (de) 2011-06-02 2019-04-18 Raindance Technologies, Inc. Enzymquantifizierung
US8841071B2 (en) 2011-06-02 2014-09-23 Raindance Technologies, Inc. Sample multiplexing
US8658430B2 (en) 2011-07-20 2014-02-25 Raindance Technologies, Inc. Manipulating droplet size
WO2013120089A1 (en) 2012-02-10 2013-08-15 Raindance Technologies, Inc. Molecular diagnostic screening assay
EP3524693A1 (de) 2012-04-30 2019-08-14 Raindance Technologies, Inc. Digitale analytanalyse
EP2986762B1 (de) 2013-04-19 2019-11-06 Bio-Rad Laboratories, Inc. Digitale analyse von analyten
US11901041B2 (en) 2013-10-04 2024-02-13 Bio-Rad Laboratories, Inc. Digital analysis of nucleic acid modification
US9944977B2 (en) 2013-12-12 2018-04-17 Raindance Technologies, Inc. Distinguishing rare variations in a nucleic acid sequence from a sample
WO2015103367A1 (en) 2013-12-31 2015-07-09 Raindance Technologies, Inc. System and method for detection of rna species
WO2016044510A1 (en) 2014-09-17 2016-03-24 Hologic, Inc. Method of partial lysis and assay
DK3198034T3 (da) 2014-09-22 2021-11-15 Univ Groningen Biomarkører for cervixcancer
US10647981B1 (en) 2015-09-08 2020-05-12 Bio-Rad Laboratories, Inc. Nucleic acid library generation methods and compositions
US10998178B2 (en) 2017-08-28 2021-05-04 Purdue Research Foundation Systems and methods for sample analysis using swabs

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6342491B1 (en) * 1991-05-21 2002-01-29 American Home Products Corporation Method of treating estrogen receptor positive carcinoma with 17 α-dihydroequilin
US6331393B1 (en) * 1999-05-14 2001-12-18 University Of Southern California Process for high-throughput DNA methylation analysis
CA2404568A1 (en) * 2000-03-31 2001-10-11 University Of Southern California Epigenetic sequences for esophageal adenocarcinoma
AUPQ901700A0 (en) * 2000-07-26 2000-08-17 National Cancer Centre Of Singapore Pte Ltd Molecular markers
CN101044247B (zh) * 2002-08-20 2011-06-22 千年药品公司 用于鉴定,评估,预防和治疗子宫颈癌的组合物,试剂盒及方法
WO2004087957A2 (en) * 2003-04-03 2004-10-14 Oncomethylome Sciences S.A. Hypermethylated genes and cervical cancer
EP1685260A2 (de) * 2003-11-10 2006-08-02 Epigenomics AG Verfahren zur analyse gynäkologischer zellproliferationsstörungen

Also Published As

Publication number Publication date
WO2006007980A2 (en) 2006-01-26
ATE408032T1 (de) 2008-09-15
EP1985715A3 (de) 2008-12-31
CA2574165A1 (en) 2006-01-26
EP1769087B1 (de) 2008-09-10
EP1985715A2 (de) 2008-10-29
EP1769087A2 (de) 2007-04-04
WO2006007980A3 (en) 2006-04-06
US20090023137A1 (en) 2009-01-22

Similar Documents

Publication Publication Date Title
DE602005009702D1 (de) Esr1 und gebärmutterhalskrebs
EA200702203A1 (ru) Способы и нуклеиновые кислоты для анализов клеточных пролиферативных нарушений
WO2004066941A3 (en) Expression profiles for colon cancer and methods of use
WO2008039769A3 (en) Methods and devices for analyzing small rna molecules
SI1687609T1 (sl) Fluorescenäśne sonde za detekcijo dna s hibridizacijo z izboljĺ ano obäśutljivostjo in nizkim ozadjem
WO2006033020A3 (en) Methods and apparatus for the detection and validation of micrornas
ATE450547T1 (de) Eml4-alk-fusionsgen
TW200720441A (en) New labelling strategies for the sensitive detection of analytes
WO2006028601A3 (en) Method for distinguishing methicillin resistant s. aureus from methicillin sensitive s. aureus in a mixed culture
WO2013033629A3 (en) Methods and compositions for the treatment and diagnosis of colorectal cancer
WO2007135568A3 (en) A METHOD FOR PREDICTING RESPONSIVENESS TO TNFα BLOCKING AGENTS
PL1895015T3 (pl) Sposób i zestaw do wykrywania gatunków bakteryjnych za pomocą analizy DNA
WO2007058968A3 (en) Gene expression profiles and methods of use
DE60330399D1 (de) Trichmikroskopie, kultur und polymerasekettenreaktion unter verwendung prozessierter klinischer proben und kit davon
WO2008109423A8 (en) Multigene assay to predict outcome in an individual with glioblastoma
WO2005059108A3 (en) Gene expression profiles and methods of use
WO2006037462A3 (en) Cancer markers
EP2254897A4 (de) Verfahren, reagentien und kits zum nachweis von nukleinsäuremolekülen
WO2005032495A3 (en) Gene expression profiles and methods of use
PT1907588E (pt) Ensaios para determinação da resistência aos medicamentos da classe das equinocandinas
DE602006013333D1 (de) Kit und verfahren zum nachweis von urothelkarzinom
WO2011133949A3 (en) Genetic risk analysis in reward deficiency syndrome
WO2005100611A3 (en) Detection of viral nucleic acid and method for reverse transcribing rna
WO2006022619A3 (en) Methods for identifying risk of type ii diabetes and treatments thereof
WO2007041238A3 (en) Methods of identification and use of gene signatures

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8328 Change in the person/name/address of the agent

Representative=s name: WESTENDORP SOMMER, 80336 MUENCHEN

8339 Ceased/non-payment of the annual fee